These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 20814939)

  • 1. Signal transduction during activation and inhibition of natural killer cells.
    Watzl C; Long EO
    Curr Protoc Immunol; 2010 Aug; Chapter 11():Unit 11.9B. PubMed ID: 20814939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How to trigger a killer: modulation of natural killer cell reactivity on many levels.
    Watzl C
    Adv Immunol; 2014; 124():137-70. PubMed ID: 25175775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dendritic cell interactions with NK cells from different tissues.
    Ferlazzo G; Münz C
    J Clin Immunol; 2009 May; 29(3):265-73. PubMed ID: 19280325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Controlling natural killer cell responses: integration of signals for activation and inhibition.
    Long EO; Kim HS; Liu D; Peterson ME; Rajagopalan S
    Annu Rev Immunol; 2013; 31():227-58. PubMed ID: 23516982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activating and inhibitory receptors of natural killer cells.
    Pegram HJ; Andrews DM; Smyth MJ; Darcy PK; Kershaw MH
    Immunol Cell Biol; 2011 Feb; 89(2):216-24. PubMed ID: 20567250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Receptors and lytic mediators regulating anti-tumor activity by the leukemic killer T cell line TALL-104.
    Brando C; Mukhopadhyay S; Kovacs E; Medina R; Patel P; Catina TL; Campbell KS; Santoli D
    J Leukoc Biol; 2005 Aug; 78(2):359-71. PubMed ID: 15937142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular mechanisms of natural killer cell activation.
    Bryceson YT; Chiang SC; Darmanin S; Fauriat C; Schlums H; Theorell J; Wood SM
    J Innate Immun; 2011; 3(3):216-26. PubMed ID: 21454962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Whatever turns you on: accessory-cell-dependent activation of NK cells by pathogens.
    Newman KC; Riley EM
    Nat Rev Immunol; 2007 Apr; 7(4):279-91. PubMed ID: 17380157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human natural killer receptors, co-receptors, and their ligands.
    Biassoni R
    Curr Protoc Immunol; 2009 Feb; Chapter 14():14.10.1-14.10.40. PubMed ID: 19235767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulatory NK cells in autoimmune disease.
    Tian Z; Gershwin ME; Zhang C
    J Autoimmun; 2012 Sep; 39(3):206-15. PubMed ID: 22704425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dendritic cells mediate NK cell help for Th1 and CTL responses: two-signal requirement for the induction of NK cell helper function.
    Mailliard RB; Son YI; Redlinger R; Coates PT; Giermasz A; Morel PA; Storkus WJ; Kalinski P
    J Immunol; 2003 Sep; 171(5):2366-73. PubMed ID: 12928383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Signal transduction during natural killer cell activation.
    Chini CC; Leibson PJ
    Curr Protoc Immunol; 2001 May; Chapter 11():Unit 11.9B. PubMed ID: 18432709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular liaisons of natural killer lymphocytes in immunology and immunotherapy of cancer.
    Arina A; Murillo O; Dubrot J; Azpilikueta A; Alfaro C; Pérez-Gracia JL; Bendandi M; Palencia B; Hervás-Stubbs S; Melero I
    Expert Opin Biol Ther; 2007 May; 7(5):599-615. PubMed ID: 17477799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The dual-functional capability of cytokine-induced killer cells and application in tumor immunology.
    Zhang Q; Liu XY; Zhang T; Zhang XF; Zhao L; Long F; Liu ZK; Wang EH
    Hum Immunol; 2015 May; 76(5):385-91. PubMed ID: 25305457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Line of attack: NK cell specificity and integration of signals.
    Bryceson YT; Long EO
    Curr Opin Immunol; 2008 Jun; 20(3):344-52. PubMed ID: 18439809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NK cell inhibitory receptors prevent tyrosine phosphorylation of the activation receptor 2B4 (CD244).
    Watzl C; Stebbins CC; Long EO
    J Immunol; 2000 Oct; 165(7):3545-8. PubMed ID: 11034353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NK cells: immune cross-talk and therapeutic implications.
    Malhotra A; Shanker A
    Immunotherapy; 2011 Oct; 3(10):1143-66. PubMed ID: 21995569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Re-educating natural killer cells.
    Sun JC
    J Exp Med; 2010 Sep; 207(10):2049-52. PubMed ID: 20876314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Minimal requirement for induction of natural cytotoxicity and intersection of activation signals by inhibitory receptors.
    Bryceson YT; Ljunggren HG; Long EO
    Blood; 2009 Sep; 114(13):2657-66. PubMed ID: 19628705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Designing multivalent proteins based on natural killer cell receptors and their ligands as immunotherapy for cancer.
    Smits NC; Coupet TA; Godbersen C; Sentman CL
    Expert Opin Biol Ther; 2016 Sep; 16(9):1105-12. PubMed ID: 27248342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.